Cargando…
Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis
Tumor necrosis factor (TNF) is known to play a critical role in the pathogenesis of rheumatoid arthritis (RA). Etanercept is a recombinant soluble fusion protein of TNFα type II receptor and IgG, which acts as a specific TNF-α antagonist. Anti-TNF-α therapy has been an important advance in the treat...
Autores principales: | Kang, Min-Jung, Lee, You-Hyun, Lee, Jisoo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722012/ https://www.ncbi.nlm.nih.gov/pubmed/17043436 http://dx.doi.org/10.3346/jkms.2006.21.5.946 |
Ejemplares similares
-
Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
por: Kang, Min-Jung, et al.
Publicado: (2007) -
Azathioprine/etanercept: Systemic lupus erythematosus flare: case report
Publicado: (2021) -
Encapsulating Peritoneal Sclerosis in Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Systemic Sclerosis
por: Matsuda, Mayumi, et al.
Publicado: (2022) -
Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis
por: Durel, Cécile-Audrey, et al.
Publicado: (2013) -
Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
por: Echeverri, Andrés F., et al.
Publicado: (2015)